Cue Health (NASDAQ: HLTH)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-11-09 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.460 | -0.370 | 0.0900 | ||||
REV | 52.900M | 87.700M | 34.800M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Cue Health (NASDAQ: HLTH) through any online brokerage.
Other companies in Cue Health’s space includes: Heska (NASDAQ:HSKA), Axogen (NASDAQ:AXGN), SI-BONE (NASDAQ:SIBN), Sight Sciences (NASDAQ:SGHT) and Semler Scientific (NASDAQ:SMLR).
The latest price target for Cue Health (NASDAQ: HLTH) was reported by Morgan Stanley on Thursday, August 11, 2022. The analyst firm set a price target for 8.00 expecting HLTH to rise to within 12 months (a possible 86.48% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Cue Health (NASDAQ: HLTH) is $4.29 last updated August 16, 2022, 8:00 PM UTC.
There are no upcoming dividends for Cue Health.
Cue Health’s Q3 earnings are confirmed for Wednesday, November 9, 2022.
There is no upcoming split for Cue Health.
Cue Health is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.